She a classic "Past caster"
The second the ARDS results are conclusively a pass, watch the re-rate happen.
It's factored in that they believe it will fail...... they will fail, all of them - ARDS, back pain and heart failure trials.
Even just the AGVHD market, if JCR made it to 3 million USD in royalties a quarter ( and growing ), and the US is 8 times bigger - we are looking at somewhere between 100 million ( if mesoblast make the same royalty figure that JCR pay ) to maybe 300 - 500 million if they bring to market themselves. That alone would suggest another re-rate is needed on aGvHD approval
MSB Trading - 2020, page-20323
-
- There are more pages in this discussion • 2,838 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
0.090(6.55%) |
Mkt cap ! $1.644B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.48 | $1.38 | $5.695M | 3.997M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 418 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 43084 | 16 |
View Market Depth
| Last trade - 15.06pm 17/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |